Partners Behind an MS Drug Take Their Dispute to Court
Thursday, August 6, 2009 - 23:42
in Psychology & Sociology
Biogen says its partner, Elan, has violated their deal to share ownership of the drug Tysabri. Elan says it has not.
Updated by artificial intelligence Thu, 13 Mar 2025, 3:35:01 UTC Learn more
- Tell your friends
- Get science news via